Unilife's US syringe deal injects excitementMarket juniors have largely given up gains made early in the week and will probably will probably end the week flat, but investors should be thankful for small mercies......
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”